GUFICBIO.NS

Gufic Biosciences Limited GUFICBIO.NS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode GUFICBIO.NS ORCHPHARMA.NS SHILPAMED.BO RPGLIFE.BO RPGLIFE.NS UNICHEMLAB.NS UNICHEMLAB.BO HIKAL.NS HIKAL.BO IOLCP.BO
6M 0.50 % -9.37 % 8.16 % 4.58 % 4.52 % -26.57 % -26.52 % -43.37 % -43.45 % 44.15 %
YTD -22.98 % -60.51 % -56.40 % 3.57 % 3.70 % -36.71 % -36.63 % -40.42 % -40.49 % 18.44 %
1Y -21.88 % -44.79 % -56.93 % -17.33 % -17.17 % -38.59 % -38.83 % -35.34 % -35.28 % 19.82 %
3Y 68.78 % 109.86 % 113.93 % 164.46 % 166.16 % 20.21 % 11.27 % -27.66 % -27.70 % 34.61 %
5Y 296.00 % 3 926.94 % 49.31 % 505.02 % 507.49 % 89.36 % 11.27 % 38.93 % 39.40 % -27.53 %
10Y 772.58 % 3 926.94 % 48.42 % 1 020.57 % 1 019.04 % 59.62 % 11.27 % 160.95 % 161.53 % 505.59 %
From the beginning 1 047.68 % 3 926.94 % 34 482.52 % 5 092.70 % 6 833.94 % 1 778.33 % 11.27 % 2 376.78 % 460.25 % 10 294.46 %

Dividend

Gufic Biosciences Limited

Orchid Pharma Limited

Shilpa Medicare Limited

RPG Life Sciences Limited

RPG Life Sciences Limited

Unichem Laboratories Limited

Unichem Laboratories Limited

Hikal Limited

Hikal Limited

IOL Chemicals and Pharmaceuticals Limited